PFS & Injectable Drug Devices Europe 2027 will bring together pharmaceutical, biotechnology, medical device and drug delivery professionals in London from 12–14 January 2027 to explore the latest innovations in pre-filled syringes, injectable drug delivery devices, combination products and primary packaging.
The three-day programme will feature presentations and discussions from experts across the pharmaceutical and biotechnology sectors. Key topics will include next-generation pre-filled syringe technologies, large-volume drug delivery, novel injectable delivery systems, device development, quality by design, design controls, human factors and patient-centric drug delivery.
Regulatory and compliance considerations will also be a major focus, with sessions exploring combination product regulations, Article 117, notified body requirements and evolving European regulatory expectations. These discussions will help companies understand the changing requirements for developing and commercialising injectable drug-device products in Europe.
The conference will also examine the growing importance of sustainability in pharmaceutical packaging and drug delivery devices, including circular economy approaches, lifecycle carbon assessment and sustainable packaging strategies.
With 250+ attendees, 50+ expert speakers, interactive roundtables and dedicated networking opportunities, PFS & Injectable Drug Devices Europe 2027 offers pharmaceutical and biotech professionals an opportunity to share knowledge, discover new technologies and connect with senior industry decision-makers.
The event is particularly relevant for professionals involved in pre-filled syringes, injectable drug delivery, combination products, medical device development, primary packaging, pharmaceutical manufacturing, regulatory affairs and human factors engineering.
For more information about the event, Click Here.